Trial updateRetina
Geographic atrophy: the SIGLEC record is updated
ClinicalTrials.gov lists the phase II AVD-104 study as completed. The registry record was updated on 16 September; no results are posted in the retrieved record.
Why it matters
A concrete checkpoint for a geographic atrophy watchlist. Registry completion and publication of results are separate events.
Keep in mind
Registry metadata supplied by the sponsor. This snapshot does not establish when the status changed or demonstrate efficacy.